Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Eleda in connection with the acquisition of Gatu och Väg Väst AB
Mandate

Vinge advises Eleda in connection with the acquisition of Gatu och Väg Väst AB

January 15, 2021 Employment and Benefits EU, Competition and Regulatory Real Estate and Construction M&A Corporate Crime & Compliance

Vinge has advised Eleda Infra Services Group (“Eleda”) on the acquisition of Gatu och Väg Väst AB (“GVV”).

GVV is based in Gunnilse and conducts construction and contracting operations in the south western Sweden, focusing on concrete maintenance work on, inter alia, bridges, power plants and port facilities. GVV has approximately 70 employees and yearly sales of around SEK 240 million. The company’s management team will continue in their respective operational management roles and become shareholders of the Eleda group.

Closing of the transaction is subject to applicable competition law approvals and other customary closing conditions.

Vinge’s team consisted primarily of partner Christina Kokko and associates Michaela Cronemyr and Carl Fredrik Wachtmeister (M&A), Isak Willborg (Agreements), Ebba Svenburg (Employment), Frida Ställborn (Real Property & Environment), Johan Wahlbom and Joel Kokko (Competition), Tove Lövgren Frisk (Compliance) and Carl Bruneheim (VDR-specialist).

 

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025